While Cartesian Therapeutics Inc has overperformed by 3.83%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RNAC fell by -57.57%, with highs and lows ranging from $26.50 to $5.98, whereas the simple moving average fell by -33.86% in the last 200 days.
On July 09, 2025, Wedbush started tracking Cartesian Therapeutics Inc (NASDAQ: RNAC) recommending Outperform. A report published by BTIG Research on December 19, 2024, Initiated its previous ‘Buy’ rating for RNAC. Oppenheimer initiated its ‘Outperform’ rating for RNAC, as published in its report on June 04, 2024. Mizuho’s report from May 24, 2024 suggests a price prediction of $40 for RNAC shares, giving the stock a ‘Buy’ rating. H.C. Wainwright also rated the stock as ‘Buy’.
Analysis of Cartesian Therapeutics Inc (RNAC)
Further, the quarter-over-quarter decrease in sales is -98.65%, showing a negative trend in the upcoming months.
Cartesian Therapeutics Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -938.38% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 13.33, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and RNAC has an average volume of 103.25K. On a monthly basis, the volatility of the stock is set at 8.24%, whereas on a weekly basis, it is put at 5.71%, with a gain of 6.29% over the past seven days. Furthermore, long-term investors anticipate a median target price of $35.29, showing growth from the present price of $7.6, which can serve as yet another indication of whether RNAC is worth investing in or should be passed over.
How Do You Analyze Cartesian Therapeutics Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 63.59%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 19.49% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
